Global Biopharmaceutical Contract Manufacturing Market by Manufacturers, Countries, Type and Application, Forecast to 2023

  • receipt Report ID : 148244
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 129
  • list Pharmaceuticals and Healthcare

A contract manufacturer ("CM") is a manufacturer that contracts with a firm for components or products. It is a form of outsourcing. A contract manufacturer performing packaging operations is called copacker or a contract packager.

Scope of the Report:

This report studies the Biopharmaceutical Contract Manufacturing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biopharmaceutical Contract Manufacturing market by product type and applications/end industries.

In terms of application, the global biopharmaceutical contract manufacturing market is divided into several sections. Among them, oncology is the biggest downstream user who has a market share of 21.3% in 2017.

The global Biopharmaceutical Contract Manufacturing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Biopharmaceutical Contract Manufacturing.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Lonza Group

Baxter Biopharma Solutions

Samsung

Fujifilm Diosynth Biotechnologies

Boehringer Ingelheim

Patheon

Rentschler Biotechnologie

Biomeva

Probiogen

Cytovance Biologics

KBI Biopharma

WuXi Biologics

Abzena

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Growth Factors

Interferons

Monoclonal Antibodies

Recombinant Hormones

Vaccines

Insulin

Others

Market Segment by Applications, can be divided into

Autoimmune Diseases

Oncology

Metabolic Diseases

Ophthalmology

Cardiovascular Diseases

Infectious Diseases

Neurology

Respiratory Disorders

Others

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Biopharmaceutical Contract Manufacturing Market Overview

1.1 Product Overview and Scope of Biopharmaceutical Contract Manufacturing

1.2 Classification of Biopharmaceutical Contract Manufacturing by Types

1.2.1 Global Biopharmaceutical Contract Manufacturing Revenue Comparison by Types (2017-2023)

1.2.2 Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Types in 2017

1.2.3 Growth Factors

1.2.4 Interferons

1.2.5 Monoclonal Antibodies

1.2.6 Recombinant Hormones

1.2.7 Vaccines

1.2.8 Insulin

1.2.9 Others

1.3 Global Biopharmaceutical Contract Manufacturing Market by Application

1.3.1 Global Biopharmaceutical Contract Manufacturing Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Autoimmune Diseases

1.3.3 Oncology

1.3.4 Metabolic Diseases

1.3.5 Ophthalmology

1.3.6 Cardiovascular Diseases

1.3.7 Infectious Diseases

1.3.8 Neurology

1.3.9 Respiratory Disorders

1.3.10 Others

1.4 Global Biopharmaceutical Contract Manufacturing Market by Regions

1.4.1 Global Biopharmaceutical Contract Manufacturing Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Biopharmaceutical Contract Manufacturing Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Biopharmaceutical Contract Manufacturing Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biopharmaceutical Contract Manufacturing Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Biopharmaceutical Contract Manufacturing Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biopharmaceutical Contract Manufacturing Status and Prospect (2013-2023)

1.5 Global Market Size of Biopharmaceutical Contract Manufacturing (2013-2023)

2 Manufacturers Profiles

2.1 Lonza Group

2.1.1 Business Overview

2.1.2 Biopharmaceutical Contract Manufacturing Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Lonza Group Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2016-2017)

2.2 Baxter Biopharma Solutions

2.2.1 Business Overview

2.2.2 Biopharmaceutical Contract Manufacturing Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2016-2017)

2.3 Samsung

2.3.1 Business Overview

2.3.2 Biopharmaceutical Contract Manufacturing Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Samsung Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2016-2017)

2.4 Fujifilm Diosynth Biotechnologies

2.4.1 Business Overview

2.4.2 Biopharmaceutical Contract Manufacturing Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2016-2017)

2.5 Boehringer Ingelheim

2.5.1 Business Overview

2.5.2 Biopharmaceutical Contract Manufacturing Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2016-2017)

2.6 Patheon

2.6.1 Business Overview

2.6.2 Biopharmaceutical Contract Manufacturing Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Patheon Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2016-2017)

2.7 Rentschler Biotechnologie

2.7.1 Business Overview

2.7.2 Biopharmaceutical Contract Manufacturing Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2016-2017)

2.8 Biomeva

2.8.1 Business Overview

2.8.2 Biopharmaceutical Contract Manufacturing Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Biomeva Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2016-2017)

2.9 Probiogen

2.9.1 Business Overview

2.9.2 Biopharmaceutical Contract Manufacturing Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Probiogen Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2016-2017)

2.10 Cytovance Biologics

2.10.1 Business Overview

2.10.2 Biopharmaceutical Contract Manufacturing Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Cytovance Biologics Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2016-2017)

2.11 KBI Biopharma

2.11.1 Business Overview

2.11.2 Biopharmaceutical Contract Manufacturing Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 KBI Biopharma Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2016-2017)

2.12 WuXi Biologics

2.12.1 Business Overview

2.12.2 Biopharmaceutical Contract Manufacturing Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 WuXi Biologics Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2016-2017)

2.13 Abzena

2.13.1 Business Overview

2.13.2 Biopharmaceutical Contract Manufacturing Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Abzena Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2016-2017)

3 Global Biopharmaceutical Contract Manufacturing Market Competition, by Players

3.1 Global Biopharmaceutical Contract Manufacturing Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Biopharmaceutical Contract Manufacturing Players Market Share

3.2.2 Top 10 Biopharmaceutical Contract Manufacturing Players Market Share

3.3 Market Competition Trend

4 Global Biopharmaceutical Contract Manufacturing Market Size by Regions

4.1 Global Biopharmaceutical Contract Manufacturing Revenue and Market Share by Regions

4.2 North America Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)

4.3 Europe Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)

4.5 South America Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)

5 North America Biopharmaceutical Contract Manufacturing Revenue by Countries

5.1 North America Biopharmaceutical Contract Manufacturing Revenue by Countries (2013-2018)

5.2 USA Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)

5.3 Canada Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)

5.4 Mexico Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)

6 Europe Biopharmaceutical Contract Manufacturing Revenue by Countries

6.1 Europe Biopharmaceutical Contract Manufacturing Revenue by Countries (2013-2018)

6.2 Germany Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)

6.3 UK Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)

6.4 France Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)

6.5 Russia Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)

6.6 Italy Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Biopharmaceutical Contract Manufacturing Revenue by Countries

7.1 Asia-Pacific Biopharmaceutical Contract Manufacturing Revenue by Countries (2013-2018)

7.2 China Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)

7.3 Japan Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)

7.4 Korea Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)

7.5 India Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)

8 South America Biopharmaceutical Contract Manufacturing Revenue by Countries

8.1 South America Biopharmaceutical Contract Manufacturing Revenue by Countries (2013-2018)

8.2 Brazil Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)

8.3 Argentina Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)

8.4 Colombia Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Biopharmaceutical Contract Manufacturing by Countries

9.1 Middle East and Africa Biopharmaceutical Contract Manufacturing Revenue by Countries (2013-2018)

9.2 Saudi Arabia Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)

9.3 UAE Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)

9.4 Egypt Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)

9.5 Nigeria Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)

9.6 South Africa Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)

10 Global Biopharmaceutical Contract Manufacturing Market Segment by Type

10.1 Global Biopharmaceutical Contract Manufacturing Revenue and Market Share by Type (2013-2018)

10.2 Global Biopharmaceutical Contract Manufacturing Market Forecast by Type (2018-2023)

10.3 Growth Factors Revenue Growth Rate (2013-2023)

10.4 Interferons Revenue Growth Rate (2013-2023)

10.5 Monoclonal Antibodies Revenue Growth Rate (2013-2023)

10.6 Recombinant Hormones Revenue Growth Rate (2013-2023)

10.7 Vaccines Revenue Growth Rate (2013-2023)

10.8 Insulin Revenue Growth Rate (2013-2023)

10.9 Others Revenue Growth Rate (2013-2023)

11 Global Biopharmaceutical Contract Manufacturing Market Segment by Application

11.1 Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Application (2013-2018)

11.2 Biopharmaceutical Contract Manufacturing Market Forecast by Application (2018-2023)

11.3 Autoimmune Diseases Revenue Growth (2013-2018)

11.4 Oncology Revenue Growth (2013-2018)

11.5 Metabolic Diseases Revenue Growth (2013-2018)

11.6 Ophthalmology Revenue Growth (2013-2018)

11.7 Cardiovascular Diseases Revenue Growth (2013-2018)

11.8 Infectious Diseases Revenue Growth (2013-2018)

11.9 Neurology Revenue Growth (2013-2018)

11.10 Respiratory Disorders Revenue Growth (2013-2018)

11.11 Others Revenue Growth (2013-2018)

12 Global Biopharmaceutical Contract Manufacturing Market Size Forecast (2018-2023)

12.1 Global Biopharmaceutical Contract Manufacturing Market Size Forecast (2018-2023)

12.2 Global Biopharmaceutical Contract Manufacturing Market Forecast by Regions (2018-2023)

12.3 North America Biopharmaceutical Contract Manufacturing Revenue Market Forecast (2018-2023)

12.4 Europe Biopharmaceutical Contract Manufacturing Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Biopharmaceutical Contract Manufacturing Revenue Market Forecast (2018-2023)

12.6 South America Biopharmaceutical Contract Manufacturing Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Biopharmaceutical Contract Manufacturing Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Biopharmaceutical Contract Manufacturing Picture

Table Product Specifications of Biopharmaceutical Contract Manufacturing

Table Global Biopharmaceutical Contract Man

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery